NHS Long-Term Plan - Our Statement

11 January 2019

ARTP are delighted that respiratory is finally a clinical priority for NHSE and that there is a strategy in place to address earlier diagnosis of disease, it's management and prevention. Lung disease is one of the top three killers, with 115,000 people dying each year. Despite its prevalence, we haven’t seen any improvements in the number of people dying from lung disease in over 10 years, unlike other diseases such as cancer, heart disease and stroke.

We therefore believe there is still more that can be done as whilst there are some good quality and effective services, outcomes remain behind other European countries. It is vital there is an appropriate workforce to meet the demands of this strategy, an issue recognised by the recent Taskforce for Lung Health document. Healthcare scientists and physiologists will be at the forefront of assisting with earlier diagnosis of lung disease and monitoring responses to interventions, as well as impacting on many other areas of the strategy. ARTP and its members are committed to assisting deliver this long term strategy, wherever our expertise is required.

Return to news listings



This home page of this section displays all current and past news items.

You can use the category filter and/or the year tabs to narrow down your search.

RSS IconTIP: You can have new content delivered directly to your Email by subscribing to the RSS Feed at the bottom of the homepage.

  • Association for Respiratory Technology & Physiology
    • Tel: 0845 226 3062
    • Fax: 0121 355 2420
    • Limited Company No. 5987719
    • Registered Charity No. 1117470
    • Connect with us